Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients
Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The present proof of concept study addresses the following specific aims:
The general objectives of this work are:
1. To increase and maintain the functional beta-cell mass after islet transplantation under
a condition of low-dose tacrolimus
2. To co-investigate the potential of alternative sites for encapsulated beta-cells